文献速递肺栓塞与肺血管病

长链非编码RNA TYKRIL通过p53介导的PDGFRβ调控在肺动脉高压中发挥作用

Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFRβ.
PubMed 文献 · Am J Respir Crit Care Med · 2020-01-01

该研究通过RNA测序发现TYKRIL在缺氧及特发性PAH来源的周细胞和肺动脉平滑肌细胞中持续上调,敲低TYKRIL可逆转促增殖和抗凋亡表型,并在PAH患者精切肺切片中减少血管重塑。机制上TYKRIL结合p53 N端干扰p53-p300相互作用,调控p53核转位及PDGFRβ表达,提示TYKRIL通过p53/PDGFRβ轴参与PAH。

要点

  • TYKRIL在缺氧及特发性PAH来源的周细胞和肺动脉平滑肌细胞中持续上调。
  • 敲低TYKRIL可逆转促增殖和抗凋亡表型,并在PAH患者精切肺切片中减少血管重塑。
  • TYKRIL通过结合p53 N端干扰p53-p300相互作用并调控PDGFRβ表达。

核心结论

  • TYKRIL通过调控p53/PDGFRβ轴在肺动脉高压中发挥重要作用。

研究设计与样本

  • 研究对缺氧及特发性PAH患者来源的周细胞和肺动脉平滑肌细胞进行RNA测序。
  • 在上述原代细胞及PAH患者精切肺切片中进行TYKRIL敲低实验。
  • 利用p53突变体RNA免疫沉淀和邻位连接实验分析TYKRIL与p53的相互作用。

主要发现

  • TYKRIL在缺氧及特发性PAH来源的周细胞和肺动脉平滑肌细胞中持续上调。
  • 敲低TYKRIL逆转促增殖(n=3)和抗凋亡(n=3)表型。
  • PAH患者精切肺切片中敲低TYKRIL减少血管重塑(n=5),血管内PCNA阳性细胞减少而TUNEL阳性细胞增加。
  • 患者样本中PDGFRβ表达与TYKRIL表达强相关(n=12),敲低TYKRIL降低PDGFRβ表达(n=3)。
  • TYKRIL结合p53 N端并干扰p53-p300相互作用(n=3),调控p53核转位。

局限性

  • TYKRIL物种保守性差,体内研究受限,ex vivo研究采用PAH患者精切肺切片。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Long noncoding RNAs (lncRNAs) are emerging as important regulators of diverse biological functions. Their role in pulmonary arterial hypertension (PAH) remains to be explored.Objectives: To elucidate the role of TYKRIL (tyrosine kinase receptor-inducing lncRNA) as a regulator of p53/ PDGFRβ (platelet-derived growth factor receptor β) signaling pathway and to investigate its role in PAH.Methods: Pericytes and pulmonary arterial smooth muscle cells exposed to hypoxia and derived from patients with idiopathic PAH were analyzed with RNA sequencing. TYKRIL knockdown was performed in above-mentioned human primary cells and in precision-cut lung slices derived from patients with PAH.Measurements and Main Results: Using RNA sequencing data, TYKRIL was identified to be consistently upregulated in pericytes and pulmonary arterial smooth muscles cells exposed to hypoxia and derived from patients with idiopathic PAH. TYKRIL knockdown reversed the proproliferative (n = 3) and antiapoptotic (n = 3) phenotype induced under hypoxic and idiopathic PAH conditions. Owing to the poor species conservation of TYKRIL, ex vivo studies were performed in precision-cut lung slices from patients with PAH. Knockdown of TYKRIL in precision-cut lung slices decreased the vascular remodeling (n = 5). The number of proliferating cell nuclear antigen-positive cells in the vessels was decreased and the number of terminal deoxynucleotide transferase-mediated dUTP nick end label-positive cells in the vessels was increased in the LNA (locked nucleic acid)-treated group compared with control. Expression of PDGFRβ, a key player in PAH, was found to strongly correlate with TYKRIL expression in the patient samples (n = 12), and TYKRIL knockdown decreased PDGFRβ expression (n = 3). From the transcription factor-screening array, it was observed that TYKRIL knockdown increased the p53 activity, a known repressor of PDGFRβ. RNA immunoprecipitation using various p53 mutants demonstrated that TYKRIL binds to the N-terminal of p53 (an important region for p300 interaction with p53). The proximity ligation assay revealed that TYKRIL interferes with the p53-p300 interaction (n = 3) and regulates p53 nuclear translocation.Conclusions: TYKRIL plays an important role in PAH by regulating the p53/PDGFRβ axis.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Zehendner CM, Valasarajan C, Werner A, et al. Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFRβ. Am J Respir Crit Care Med. 2020. PMID: 32634060. doi:10.1164/rccm.201910-2041OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。